Antidiabetic Drug Therapy of African-American and White Community-Dwelling Elderly over a 10-Year Period

Journal of the American Geriatrics Society

Volumn 51, Issue 12, 2003, Pages 1748-1753

  Lindblad, Catherine I ^a,d,f   Hanlon, Joseph T ^a,b,d   Artz, Margaret B ^a   Fillenbaum, Gerda G ^e   McCarthy, Teresa C ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Aged; Drug utilization; Epidemiology; Hypoglycemic agents; Race

Indexed keywords

ACETOHEXAMIDE; ANTIDIABETIC AGENT; CHLORPROPAMIDE; GLIBENCLAMIDE; GLIPIZIDE; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE; TOLAZAMIDE; TOLBUTAMIDE;

AFRICAN AMERICAN; AGED; AGING; ARTICLE; CAUCASIAN; DIABETES MELLITUS; FEMALE; HEALTH CARE ACCESS; HEALTH STATUS; HEALTH SURVEY; HUMAN; HYPOGLYCEMIA; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRESCRIPTION; PREVALENCE; RACE;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GERIATRICS; HEALTH STATUS; HUMANS; HYPOGLYCEMIC AGENTS; INCOME; MALE; NORTH CAROLINA; POPULATION SURVEILLANCE;

EID: 0347381062     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2003.51559.x     Document Type: Article

References (28)

1. Meneilly GS, Tessier D. Diabetes in elderly adults. J Gerontol A Biol Sci Med Sci 2001;56A:MS-M13.
2. Brancati FL, Kao WHL, Folsom AR et al. Incident type 2 diabetes mellitus in African-American and white adults: The Atherosclerosis Risk in Communities Study. JAMA 2000;283:2253-2259.
3. Harris MI, Goldstein DE, Flegal KM et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. Diabetes Care 1998;21:518-524.
4. Moritz DJ, Ostfeld AM, Blazer D et al. The health burden of diabetes for the elderly in four communities. Public Health Rep 1994;109:782-790.
5. Karter AJ, Ferrara A, Liu JY et al. Ethnic disparities in diabetic complications in an insured population. JAMA 2002;287:2519-2527.
6. Yki-Jarvinen H, Kauppila M, Kujansuu E et al. Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1992;327:1426-1433.
7. Gram J, Damsgaard EM. Drug consumption in elderly diabetics. Diabetes Res Clin Pract 1989;7:293-298.
8. Graal MB, Wolffenbuttel BHR. The use of sulphonylureas in the elderly. Drugs Aging 1999;15:471-481.
9. Bourdel-Marchasson I, Dubroca B, Letenneur L et al. Incidence and predictors of drug-treated diabetes in elderly French subjects. The PAQUID Epidemiology Survey. Diabet Med 2000;17:675-681.
10. Trewin VF, Lawrence CJ, Veitch GBA et al. Changes in prescribing patterns of oral hypoglycaemics in elderly patients, over a period of 10 years: Matching with general practitioners' perceptions of their own prescribing. J Clin Pharm Ther 1996;21:243-245.
11. Cornoni-Huntley J, Blazer DG, Lafferty ME et al. Established populations for epidemiologic studies of the elderly, 2. Resource Data Book (NIH Publication no pp 90-495). Bethesda, MD: National Institute on Aging, 1990.
12. Blazer D, Hybels C, Simonsik E et al. Sedative, hypnotic and anti-anxiety medication use in an aging cohort over ten years: A racial comparison. J Am Geriatr Soc 2000;48:1073-1079.
13. Hanlon JT, Fillenbaum GG, Burchett B et al. Drug-use patterns among African American and non black community dwelling elderly. Ann Pharmacother 1992;26:679-685.
14. Kastrup EK, ed. Facts and Comparisons 2000. St. Louis: Facts and Comparisons, 2000.
15. Andersen RM. Revisiting the behavioral model and access to medical care: Does it matter? J Health Soc Behav 1995;36:1-10.
16. Molazowski S. Drug-related hyperglycemia. JAMA 2002:287:714-715.
17. Rowland ML. A nomogram for computing body mass index. Diet Curr 1989;16:5-12.
18. Rosow I, Breslau N. Guttman health scale for the aged. J Gerontol 1966;21:556-559.
19. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975;23:433-441.
20. Kalton G, Kasprzyk D. The treatment of missing survey data. Surv Methodol 1986;12:1-16.
21. Hosmer D, Lemeshow S. Applied Logistic Regression. New York: Wiley, 1989.
22. Neter J, Wasserman W, Kutner MH. Applied linear regression models. Homewood, IL: Richard D. Irwin Inc., 1989.
23. Shorr RI, Ray WA, Daugherty JR et al. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc 1996;44:751-755.
24. Calabrese AT, Coley KC, DaPos SV et al. Evaluation of prescribing practices: Risk of lactic acidosis with metformin therapy. Arch Intern Med 2002;162:434-437.
25. Morley JE. An overview of diabetes mellitus in older persons. Clin Geriatr Med 1999;15:211-224.
26. Bierman AS, Lurie N, Collins KS et al. Addressing racial and ethnic barriers to effective health care: The need for better data. Health Aff 2002;21:91-102.
27. Fillenbaum GG, Hanlon JT, Corder EH et al. Prescription and non-prescription drug use among black and white community-residing elderly. Am J Public Health 1993;83:1577-1582.
28. Schmader KE, Hanlon JT, Fillenbaum GG et al. Medication use patterns among demented, cognitively impaired and cognitively intact community-dwelling elderly people. Age Ageing 1998;27:493-501.